🟢 Jasper Therapeutics is trading 5.2% up in pre-market after two senior appointments

Jasper Therapeutics is trading 5.2% up in pre-market at $0.60 after announcing two senior appointments on September 15, 2026.

• Lisa Pitt was appointed Senior Vice President of Regulatory Affairs, and Shiguang Liu was appointed Vice President of Clinical Development.
• The company is scheduled to present at the H.C. Wainwright conference at 8:00 AM ET on September 16, 2026.
• The appointment announcement is the clearest available catalyst, although direct causation remains unconfirmed.